Additionally, genetic predispositions influencing inflammation, such as variations in interleukin genes (e.g., IL‐6, IL‐1β), may affect the degree of erythema and scarring, leading to differing outcomes among patients receiving the same treatment [20]. This evidence concerns the gene IL6 and Erythema.